Authors
-
Shanthisree Edara
Institute of Endocrinology, Diabetes, Thyroid and Osteoporosis Disorders, Sakra World Hospital, Bangalore, Karnataka State, India
Author
-
Sherin Philip
Institute of Endocrinology, Diabetes, Thyroid and Osteoporosis Disorders, Sakra World Hospital, Bangalore, Karnataka State, India
Author
-
Sushma Rani Raju
Department of Nephrology, Sakra World Hospital, Bangalore, Karnataka State, India
Author
-
Venu Madhav Reddy
Department of Nephrology, Sakra World Hospital, Bangalore, Karnataka State, India
Author
-
Anisha Tandon
Department of Radiology, Sakra World Hospitals, Bangalore, Karnataka State, India
Author
-
Harinarayan C V
Institute of Endocrinology, Diabetes, Thyroid and Osteoporosis Disorders, Sakra World Hospital, Bangalore, Karnataka State, India; Saveetha Institute of Medical and Technical Sciences University, Saveetha Medical College, Chennai, India
Author
Keywords:
Tumor Calcinosis, Hyperphosphatemia, FGF 23, GaLNAc-transferase 3 (GALNT3), Klotho, Galnt3
Abstract
Tumour calcinosis is a rare disorder of phosphate metabolism. Familial tumour calcinosis is caused due to gene mutations affecting the activity of FGF23, a phosphoturic hormone. The presentation is hyperphosphatemia and calcified deposits in the periarticular regions. Surgery though being the mainstay of treatment, recurrence is often common without additional treatment. Phosphate restricted diet and phosphate binder before and after surgery would be beneficial. We present two cases of tumour calcinosis with hyperphosphatemia and calcified deposits, evaluated and followed up. We discuss various treatment options available for this rare condition.
Author Biographies
-
Shanthisree Edara, Institute of Endocrinology, Diabetes, Thyroid and Osteoporosis Disorders, Sakra World Hospital, Bangalore, Karnataka State, India
Institute of Endocrinology, Diabetes, Thyroid and Osteoporosis Disorders, Sakra World Hospital, Bangalore, Karnataka State, India.
-
Sherin Philip, Institute of Endocrinology, Diabetes, Thyroid and Osteoporosis Disorders, Sakra World Hospital, Bangalore, Karnataka State, India
Institute of Endocrinology, Diabetes, Thyroid and Osteoporosis Disorders, Sakra World Hospital, Bangalore, Karnataka State, India.
-
Sushma Rani Raju, Department of Nephrology, Sakra World Hospital, Bangalore, Karnataka State, India
Department of Nephrology, Sakra World Hospital, Bangalore, Karnataka State, India.
-
Venu Madhav Reddy, Department of Nephrology, Sakra World Hospital, Bangalore, Karnataka State, India
Department of Nephrology, Sakra World Hospital, Bangalore, Karnataka State, India.
-
Anisha Tandon, Department of Radiology, Sakra World Hospitals, Bangalore, Karnataka State, India
Department of Radiology, Sakra World Hospitals, Bangalore, Karnataka State, India.
-
Harinarayan C V, Institute of Endocrinology, Diabetes, Thyroid and Osteoporosis Disorders, Sakra World Hospital, Bangalore, Karnataka State, India; Saveetha Institute of Medical and Technical Sciences University, Saveetha Medical College, Chennai, India
Harinarayan C V, Institute of Endocrinology, Diabetes, Thyroid and Osteoporosis Disorders, Sakra World Hospitals, Bangalore 560103, Karnataka State, INDIA.
